Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.305
+0.020 (1.56%)
Oct 9, 2026, 3:58 PM HKT

HKG:2185 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-75.5-70.05-87.94-175.89-204.24-361.45
Depreciation & Amortization
20.5518.058.0521.2720.8613.23
Other Amortization
0.120.120.120.09--
Loss (Gain) From Sale of Assets
0.01-1.4730.510-
Loss (Gain) From Sale of Investments
18.2518.2532.17-0.47--
Loss (Gain) on Equity Investments
1.211.470.991.631.43-
Stock-Based Compensation
---47.63140.48318.72
Other Operating Activities
-20.46-18.68-6.24-19.5-50.63-42.05
Change in Accounts Receivable
-15.76-17.85----
Change in Inventory
-11.29-13.86-14.35-3.98--
Change in Accounts Payable
1.882.120.1--0.01-
Change in Unearned Revenue
-21.19-0.71-0.6-0.92-0.981.37
Change in Other Net Operating Assets
30.5813.45-52.2250.6-47.53-18.3
Operating Cash Flow
-71.58-67.67-118.44-49.03-140.62-88.47
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-9.77-7.64-47.14-17.72-30.04-34.27
Sale of Property, Plant & Equipment
5.63--0.11--
Sale (Purchase) of Intangibles
----0.26--0.43
Investment in Securities
-21-188.8--15-74.66-
Other Investing Activities
1.530.45-44.010.97
Investing Cash Flow
-23.61-195.99-47.14-28.86-100.69-33.73

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--1.41-2.06-5.26-3.59-4.29
Lease Payments
-2.47-1.41-2.06-5.26-3.59-4.29
Total Debt Repaid
-2.47-1.41-2.06-5.26-3.59-4.29
Net Debt Issued (Repaid)
-2.47-1.41-2.06-5.26-3.59-4.29
Issuance of Common Stock
-----395.25
Repurchase of Common Stock
-----29.44-
Other Financing Activities
2.8155.22-0.39-0.56-2.15-7.27
Financing Cash Flow
0.34153.81-2.44-5.82-35.18383.68

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.35-0.260.971.8219.27-6.61
Net Cash Flow
-95.21-110.1-167.05-81.88-257.21254.86

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-81.35-75.3-165.58-66.74-170.65-122.75
Free Cash Flow Growth
------
Free Cash Flow Margin
-211.59%-167.59%----
Free Cash Flow Per Share
-0.33-0.31-0.68-0.27-0.70-0.56
Levered Free Cash Flow
-86.28-72.07-134.87-3.8-77.4126.76
Unlevered Free Cash Flow
-79.71-66.6-134.83-3.44-76.8127.19
Free Cash Flow After Leases
-83.82-76.71-167.64-72-174.25-127.04

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.380.380.06---
Change in Working Capital
-15.77-16.83-67.0745.71-48.52-16.93